Perrigo (PRGO) Competitors

Perrigo (NYSE:PRGO) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability.

Do insiders & institutionals have more ownership in PRGO or JAZZ?

95.9% of Perrigo shares are owned by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are owned by institutional investors. 0.7% of Perrigo shares are owned by company insiders. Comparatively, 4.2% of Jazz Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, PRGO or JAZZ?

Perrigo has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500.

Does the MarketBeat Community prefer PRGO or JAZZ?

Jazz Pharmaceuticals received 365 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 80.85% of users gave Jazz Pharmaceuticals an outperform vote while only 66.35% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Perrigo	Outperform Votes 771 66.35%	Underperform Votes 391 33.65%
Jazz Pharmaceuticals	Outperform Votes 1136 80.85%	Underperform Votes 269 19.15%

Does the media refer more to PRGO or JAZZ?

In the previous week, Jazz Pharmaceuticals had 33 more articles in the media than Perrigo. MarketBeat recorded 39 mentions for Jazz Pharmaceuticals and 6 mentions for Perrigo. Perrigo's average media sentiment score of 0.98 beat Jazz Pharmaceuticals' score of 0.54 indicating that Perrigo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Perrigo	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jazz Pharmaceuticals	11 Very Positive mention(s)	4 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Do analysts prefer PRGO or JAZZ?

Perrigo currently has a consensus target price of $33.00, indicating a potential upside of 18.22%. Jazz Pharmaceuticals has a consensus target price of $190.53, indicating a potential upside of 39.22%. Given Jazz Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Jazz Pharmaceuticals is more favorable than Perrigo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perrigo	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Jazz Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.93

Which has stronger earnings & valuation, PRGO or JAZZ?

Jazz Pharmaceuticals has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perrigo	$4.37B	0.87	-$12.70M	-$1.25	-22.33
Jazz Pharmaceuticals	$4.07B	2.04	$414.83M	$8.79	15.57

Is PRGO or JAZZ more profitable?

Jazz Pharmaceuticals has a net margin of 11.60% compared to Perrigo's net margin of -3.64%. Jazz Pharmaceuticals' return on equity of 29.30% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perrigo	-3.64%	7.38%	3.18%
Jazz Pharmaceuticals	11.60%	29.30%	9.72%

Summary

Jazz Pharmaceuticals beats Perrigo on 14 of the 18 factors compared between the two stocks.